Antimicrobial use, drug-resistant infections and COVID-19

Coronavirus disease 2019 may have a complex long-term impact on antimicrobial resistance (AMR). Coordinated strategies at the individual, health-care and policy levels are urgently required to inform necessary actions to reduce the potential longer-term impact on AMR and on access to effective antim...

Descripción completa

Detalles Bibliográficos
Autores principales: Rawson, Timothy M., Ming, Damien, Ahmad, Raheelah, Moore, Luke S. P., Holmes, Alison H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264971/
https://www.ncbi.nlm.nih.gov/pubmed/32488173
http://dx.doi.org/10.1038/s41579-020-0395-y
Descripción
Sumario:Coronavirus disease 2019 may have a complex long-term impact on antimicrobial resistance (AMR). Coordinated strategies at the individual, health-care and policy levels are urgently required to inform necessary actions to reduce the potential longer-term impact on AMR and on access to effective antimicrobials.

Ejemplares similares